One Equity Partners Completes Strategic Investment in InfuCare Rx
January 12, 2022
One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.
- Buyers
- One Equity Partners
- Targets
- InfuCare Rx
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
InfuCare Rx Founder-Led Buyback of One Equity Partners Stake
July 11, 2025
Healthcare Services
One Equity Partners has exited its investment in InfuCare Rx via a strategic, founder-led equity buyback. InfuCare Rx is a nationwide specialty infusion therapy provider treating complex and chronic conditions, operating three segments (IG Therapy, Specialty Infusion, Bleeding Disorders) and serving thousands of patients across all 50 states.
-
One Equity Partners Completes Investment in React Health
May 5, 2022
Medical Devices
One Equity Partners (OEP) completed an undisclosed investment in React Health, a Winter Haven, Florida-based manufacturer and distributor of sleep therapy, respiratory therapy and disinfection products. OEP said the investment will support React Health’s growth and innovation to expand access to diagnosis and treatment for sleep-disordered breathing and chronic respiratory conditions in out-of-hospital care settings.
-
One Equity Partners Makes Strategic Investment in Infobip
July 30, 2020
Cloud & SaaS
One Equity Partners (OEP) signed a definitive agreement to make a major strategic investment in Infobip, the Croatia-headquartered global communications platform (CPaaS). The capital will be used to support Infobip's pre-IPO growth, build its presence in North America and accelerate expansion via strategic acquisitions while keeping the founders in place.
-
BioMatrix Specialty Pharmacy Acquires InfuCare LTD (Tyler, TX)
July 6, 2021
Healthcare Services
BioMatrix Specialty Pharmacy, based in Plantation, Florida, has acquired InfuCare LTD, a home infusion specialty pharmacy in Tyler, Texas. The transaction adds a Texas brick-and-mortar location to BioMatrix's national footprint and expands its infusion capabilities, payer contracts, and access to covered lives for therapies such as IVIG, anti-infectives, and parenteral nutrition.
-
Shore Capital Partners Recapitalizes Reliant Healthcare and Merges It with Care Fusion Rx
November 23, 2025
Healthcare Services
Shore Capital Partners, via its Healthcare Advantage Fund, completed a majority recapitalization of Reliant Healthcare and merged Reliant with California-based Care Fusion Rx to form a national infusion therapy platform. The combined company will expand home and ambulatory infusion services, leveraging complementary geographic footprints and clinical capabilities to drive growth through new center openings, home infusion expansion, and further acquisitions.
-
FFL Partners Invests in Apex Infusion
June 19, 2024
Healthcare Services
FFL Partners has completed an investment in Apex Infusion, a Signal Hill, California-based provider of ambulatory infusion therapy services that operates 11 locations in California. Financial terms were not disclosed; FFL said the capital will support geographic expansion through de novo locations and strategic acquisitions to build a diversified specialty infusion platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.